09:18 AM EDT, 05/28/2025 (MT Newswires) -- Aspire Biopharma ( ASBP ) said Wednesday it expects to launch Buzz Bomb, its sublingual pre-workout supplement, in Q3.

The company has started initial production of the new supplement, which features 50mg of caffeine and is designed to support "sustained energy and mental focus."

Aspire Biopharma ( ASBP ) shares were 72% higher in premarket trading.